UK markets closed

Novo Nordisk A/S (NOVO-B.CO)

Copenhagen - Copenhagen Real-time price. Currency in DKK
Add to watchlist
514.90-4.20 (-0.81%)
At close: 4:59PM CEST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2020
31/12/2019
31/12/2018
31/12/2017
Total revenue
126,875,000
126,946,000
122,021,000
111,831,000
111,696,000
Cost of revenue
21,357,000
20,932,000
20,088,000
17,617,000
17,632,000
Gross profit
105,518,000
106,014,000
101,933,000
94,214,000
94,064,000
Operating expenses
Research development
15,629,000
15,462,000
14,220,000
14,805,000
14,014,000
Selling general and administrative
37,557,000
36,886,000
35,830,000
33,313,000
32,124,000
Total operating expenses
52,712,000
51,888,000
49,450,000
46,966,000
45,097,000
Operating income or loss
52,806,000
54,126,000
52,483,000
47,248,000
48,967,000
Interest expense
-111,000
390,000
220,000
85,000
90,000
Total other income/expenses net
-
-793,000
-3,494,000
473,000
-198,000
Income before tax
54,047,000
53,130,000
48,553,000
47,615,000
48,680,000
Income tax expense
11,183,000
10,992,000
9,602,000
8,987,000
10,550,000
Income from continuing operations
42,864,000
42,138,000
38,951,000
38,628,000
38,130,000
Net income
42,864,000
42,138,000
38,951,000
38,628,000
38,130,000
Net income available to common shareholders
42,864,000
42,138,000
38,951,000
38,628,000
38,130,000
Basic EPS
-
18.05
16.41
15.96
15.42
Diluted EPS
-
18.01
16.38
15.93
15.39
Basic average shares
-
2,333,900
2,374,299
2,419,603
2,473,218
Diluted average shares
-
2,340,000
2,378,658
2,424,417
2,478,093
EBITDA
-
59,273,000
54,434,000
51,625,000
51,952,000